US2002028944A1PendingUtilityA1

L-tartrate of trans-(-)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound and process for preparing the same

Assignee: SUMIKA FINE CHEMICALS CO LTDPriority: Jun 29, 1998Filed: Sep 27, 2001Published: Mar 7, 2002
Est. expiryJun 29, 2018(expired)· nominal 20-yr term from priority
C07D 211/22
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An L-tartrate of a trans-(−)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound, represented by the formula (I): wherein R 1 is hydrogen atom, a substituted or unsubstituted, linear or branched alkyl group having 1 to 6 carbon atoms, or an aralkyl group having 7 to 12 carbon atoms. The L-tartrate of trans-(−)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound can be suitably used as an intermediate for pharmaceuticals such as paroxetine which is useful, for example, as an antidepressant.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . An L-tartrate of a trans-(−)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound, represented by the formula (I):  
       
         
           
           
               
               
           
         
       
       wherein R 1  is hydrogen atom.  
     
     
         2 . The L-tartrate of a trans-(−)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound according to  claim 1 , wherein said L-tartrate has an optical rotation [α] 20   D  of −12.1° to −10.6°.  
     
     
         3 . The L-tartrate of a trans-(−)-4-(4-fluorophenyl)-3-hydroxymethylpiperidine compound according to  claim 1 , wherein said L-tartrate has a melting point of 160.0° to 162.3° C.

Join the waitlist — get patent alerts

Track US2002028944A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.